Please use this identifier to cite or link to this item:
https://doi.org/10.1038/onc.2010.576
Title: | A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors | Authors: | Low, J.S.W. Tao, Q. Ng, K.M. Goh, H.K. Shu, X.-S. Woo, W.L. Ambinder, R.F. Srivastava, G. Shamay, M. Chan, A.T.C. Popescu, N.C. Hsieh, W.-S. |
Keywords: | carcinoma DLC1 methylation p53 RhoGAP tumor suppressor gene |
Issue Date: | 21-Apr-2011 | Citation: | Low, J.S.W., Tao, Q., Ng, K.M., Goh, H.K., Shu, X.-S., Woo, W.L., Ambinder, R.F., Srivastava, G., Shamay, M., Chan, A.T.C., Popescu, N.C., Hsieh, W.-S. (2011-04-21). A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors. Oncogene 30 (16) : 1923-1935. ScholarBank@NUS Repository. https://doi.org/10.1038/onc.2010.576 | Abstract: | The critical 8p22 tumor suppressor deleted in liver cancer 1 (DLC1) is frequently inactivated by aberrant CpG methylation and/or genetic deletion and implicated in tumorigeneses of multiple tumor types. Here, we report the identification and characterization of its new isoform, DLC1 isoform 4 (DLC1-i4). This novel isoform encodes an 1125-aa (amino acid) protein with distinct N-terminus as compared with other known DLC1 isoforms. Similar to other isoforms, DLC1-i4 is expressed ubiquitously in normal tissues and immortalized normal epithelial cells, suggesting a role as a major DLC1 transcript. However, differential expression of the four DLC1 isoforms is found in tumor cell lines: Isoform 1 (longest) and 3 (short thus probably nonfunctional) share a promoter and are silenced in almost all cancer and immortalized cell lines, whereas isoform 2 and 4 utilize different promoters and are frequently downregulated. DLC1-i4 is significantly downregulated in multiple carcinoma cell lines, including 2/4 nasopharyngeal, 8/16 (50%) esophageal, 4/16 (25%) gastric, 6/9 (67%) breast, 3/4 colorectal, 4/4 cervical and 2/8(25%) lung carcinoma cell lines. The functional DLC1-i4 promoter is within a CpG island and is activated by wild-type p53. CpG methylation of the DLC1-i4 promoter is associated with its silencing in tumor cells and was detected in 38-100% of multiple primary tumors. Treatment with 5-aza-2′-deoxycytidine or genetic double knockout of DNMT1 and DNMT3B led to demethylation of the promoter and reactivation of its expression, indicating a predominantly epigenetic mechanism of silencing. Ectopic expression of DLC1-i4 in silenced tumor cells strongly inhibited their growth and colony formation. Thus, we identified a new isoform of DLC1 with tumor suppressive function. The differential expression of various DLC1 isoforms suggests interplay in modulating the complex activities of DLC1 during carcinogenesis. © 2011 Macmillan Publishers Limited All rights reserved. | Source Title: | Oncogene | URI: | http://scholarbank.nus.edu.sg/handle/10635/114982 | ISSN: | 09509232 | DOI: | 10.1038/onc.2010.576 |
Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.